Two-thirds of neurologists expect to start some patients on Aduhelm next year: surveySeptember 17, 2021Risk Management/SafetyTwo-thirds of neurologists surveyed early this month said that they expect to have some patients started on the new Alzheimer’s disease drug aducanumab (Aduhelm) by March 2022.